跳至主要内容
临床试验/ITMCTR2200005730
ITMCTR2200005730招募中未知

Clinical study of Longchaijiangxue granules in the treatment of myeloproliferative neoplasms

Xiyuan Hospital of China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • (1) Meets WHO diagnostic criteria for PV, ET.
  • (2) PLT < 1000 x 109/L and HCT < 60%.
  • (3) Age above 18 years (including 18 years) and below 80 years (including 80 years), with no restriction on gender.
  • (4) Voluntarily subjected to the trial and signed an informed consent form.
  • (5) Not participating in other clinical studies.

排除标准

  • (1) Cases that met the inclusion criteria but were not treated after inclusion.
  • (2) Patients with no record of testing.
  • (3) Those using prohibited drugs.

研究者

相似试验